Cited by 547Antifungal resistance and susceptibilityYeasts and Rust Fungi StudiesFungal Infections and Studies

Changes in the epidemiological landscape of invasive candidiasis

Open access
Lamoth, Frederic, Lockhart, Shawn R, Berkow, Elizabeth L, Calandra, Thierry·2018·Journal of Antimicrobial Chemotherapy

Abstract

The epidemiology of invasive candidiasis has evolved in recent years, warranting a review of the changes and the implications for current and future diagnosis and treatment. The overall burden of invasive candidiasis remains high, particularly in the expanding populations of patients at risk of opportunistic infection, such as the elderly or immunosuppressed. Progressive shifts from Candida albicans to non-albicans Candida spp. have been observed globally. The recent emergence of novel, multiresistant species, such as Candida auris, amplifies the call for vigilance in detection and advances in treatment. Among the current treatment options, fluconazole is still widely used throughout the world. Increased resistance to fluconazole, both acquired and naturally emerging, has been observed. Resistance to echinocandins is presently low but this may change with increased use. Improvement of diagnostic techniques and strategies, development of international surveillance networks and implementation of antifungal stewardship programmes represent major challenges for a better epidemiological control of invasive candidiasis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/jac/dkx444

Cites

148 of 148 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The majority of these infections in the United States have historically been caused by C. albicans, although in recent years this species is now responsible for < 50% of all Candida bloodstream infections.

    “The majority of these infections in the United States have historically been caused by C. albicans, although in recent years this species is now responsible for < 50% of all Candida bloodstream infections [4, 5].”

    From Invasive candidiasis species distribution and trends, United States, 2009-2017 (2021) · cites this paper as [5]

    The ‘Distribution trends towards non-albicans Candida species’ section (page unavailable) says that the US proportion of C. albicans has fallen significantly and is now below 50%. It does not explicitly establish that C. albicans historically caused a majority of US Candida bloodstream infections. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • Several European countries have also seen increases in the incidence of IC.

    “and several European countries have also seen increases in the incidence of IC [5, 14].”
  • Currently, there are no population-based data sources for invasive candidiasis in Asia, the Middle East, Africa, or Latin America.

    “Currently, there are no population-based data sources for Asia, the Middle East, Africa, or Latin America.44”

    From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [44]

  • Lack of standardized methodologies and denominators limit the ability to compare estimates of invasive candidiasis burden.

    “Lack of standardized methodologies and denominators limit the ability to compare estimates of IC burden.44”

    From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [44]

  • The most common sites of infection in pregnant and postpartum women are the urinary system (5.2%), reproductive system (such as chorioamnionitis, 27.6%) and respiratory system (13.8%). Other common infections include surgical incision infections and skin and soft tissue infections (3.5%).

    “The most common sites of infection in pregnant and postpartum women are the urinary system (accounting for 5.2%), reproductive system (such as chorioamnionitis, accounting for 27.6%) and respiratory system (accounting for 13.8%).35,36 Other common infections include surgical incision infections and skin and soft tissue infections (accounting for 3.5%).37,38”

    From Clinical and Pathogenic Characteristics of 45 Cases of Bloodstream Infection in Obstetrics: A Clinical Analysis (2026) · cites this paper as [35]

    Split into 2 atoms — 0 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 2 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [46]46. Magobo RE, Corcoran C, Seetharam S et al. Candida auris-associated can- didemia, South Africa. Emerg Infect Dis 2014; 20: 1250-1.

Cited by

Sorted by citations

Authors
Lamoth, F., Lockhart, S. R., Berkow, E. L., & Calandra, T.
Affiliations
  • Centers for Disease Control and Prevention (US)
  • University of Lausanne (CH)
Corresponding author
Lockhart, Shawn R
Venue
Journal of Antimicrobial Chemotherapy
Published
2018-01-01
Volume
73
Issue
suppl_1
Pages
i4-i13
ISSN
  • 0305-7453 (ISSN-L)
  • 1460-2091
OpenAlex
W2782394839
Cited by
547
References
148
Citations by year
2026: 43 · 2025: 68 · 2024: 66 · 2023: 66 · 2022: 69 · 2021: 82 · 2020: 80 · 2019: 53 · 2018: 17 · 2017: 2
FWCI
6.39
Type
journal article
Language
en
Open access
Licence
public-domain
Locations
  • Journal of Antimicrobial Chemotherapy (publishedVersion, public-domain)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • IRIS (submittedVersion)
  • SERVAL (Université de Lausanne) (submittedVersion)
Funders
  • Cidara Therapeutics
  • National Institutes of Health (CC999999)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Yeasts and Rust Fungi Studies
  • Health Sciences › Medicine › Epidemiology › Fungal Infections and Studies
Keywords
invasive candidiasis, Candida albicans, non-albicans Candida, Candida auris, fluconazole resistance, echinocandin resistance, antifungal stewardship, surveillance networks, immunocompromised patients, opportunistic fungal infection
MeSH terms
Antimicrobial Stewardship, Antifungal Agents, Candida, Humans, Global Health, Prevalence, Drug Resistance, Fungal, Candidiasis, Invasive, Epidemiological Monitoring

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review